BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 22433192)

  • 1. A prospective multicentre registry, evaluating real-world usage of the Tryton side branch stent: results of the E-Tryton 150/Benelux registry.
    Agostoni P; Foley D; Lesiak M; Belkacemi A; Dens J; Kumsars I; Scott B; Oemrawsingh P; Dubois C; Garcia E; Lefèvre T; Stella PR
    EuroIntervention; 2012 Mar; 7(11):1293-300. PubMed ID: 22433192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcome of patients with de novo coronary bifurcation lesions treated with the Tryton Side Branch Stent. The SAFE-TRY prospective multicenter single arm study.
    Tarantini G; La Vecchia L; Galli M; Favero L; D'Amico G; Buja P; Russo F; Cabianca E; Napodano M; Musumeci G; Franceschini E; Grassi G; Pavei A; Bonmassari R; Cernetti C; Spedicato L; Caprioglio F; Reimers B; Isabella G
    Int J Cardiol; 2013 Oct; 168(6):5323-8. PubMed ID: 24007969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial.
    Stella PR; Belkacemi A; Dubois C; Nathoe H; Dens J; Naber C; Adriaenssens T; van Belle E; Doevendans P; Agostoni P
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1138-46. PubMed ID: 22422607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six-month clinical follow-up of the Tryton side branch stent for the treatment of bifurcation lesions: a two center registry analysis.
    Magro M; Wykrzykowska J; Serruys PW; Simsek C; Nauta S; Lesiak M; Stanislawska K; Onuma Y; Regar E; van Domburg RT; Grajek S; Geuns RJ
    Catheter Cardiovasc Interv; 2011 May; 77(6):798-806. PubMed ID: 20824767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of a dedicated stent in coronary bifurcations with large side branches: A subanalysis of the randomized TRYTON bifurcation study.
    Généreux P; Kini A; Lesiak M; Kumsars I; Fontos G; Slagboom T; Ungi I; Metzger DC; Wykrzykowska JJ; Stella PR; Bartorelli AL; Fearon WF; Lefèvre T; Feldman RL; Tarantini G; Bettinger N; Minalu Ayele G; LaSalle L; Francese DP; Onuma Y; Grundeken MJ; Garcia-Garcia HM; Laak LL; Cutlip DE; Kaplan AV; Serruys PW; Leon MB
    Catheter Cardiovasc Interv; 2016 Jun; 87(7):1231-41. PubMed ID: 26397982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dedicated Bifurcation Stent for the Treatment of Bifurcation Lesions Involving Large Side Branches: Outcomes From the Tryton Confirmatory Study.
    Généreux P; Kumsars I; Schneider JE; Lesiak M; Redfors B; Cornelis K; Selmon MR; Dens J; Hoye A; Metzger DC; Muyldermans L; Slagboom T; Francese DP; Ayele GM; Laak LL; Bartorelli AL; Cutlip DE; Kaplan AV; Leon MB
    JACC Cardiovasc Interv; 2016 Jul; 9(13):1338-46. PubMed ID: 27388820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute procedural and six-month clinical outcome in patients treated with a dedicated bifurcation stent for left main stem disease: the TRYTON LM multicentre registry.
    Magro M; Girasis C; Bartorelli AL; Tarantini G; Russo F; Trabattoni D; D'Amico G; Galli M; Gómez Juame A; de Sousa Almeida M; Simsek C; Foley D; Sonck J; Lesiak M; Kayaert P; Serruys PW; van Geuns RJ
    EuroIntervention; 2013 Mar; 8(11):1259-69. PubMed ID: 23538155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Frontier stent registry: safety and feasibility of a novel dedicated stent for the treatment of bifurcation coronary artery lesions.
    Lefèvre T; Ormiston J; Guagliumi G; Schultheiss HP; Quilliet L; Reimers B; Brunel P; Wijns W; Buettner HJ; Hartmann F; Veldhof S; Miquel K; Su X; van der Giessen WJ
    J Am Coll Cardiol; 2005 Aug; 46(4):592-8. PubMed ID: 16098421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healing responses after bifurcation stenting with the dedicated TRYTON Side-Branch Stent™ in combination with XIENCE-V™ stents: a clinical, angiography, fractional flow reserve, and optical coherence tomography study: the PYTON (Prospective evaluation of the TRYTON Side-Branch Stent™ with an additional XIENCE-v™ everolimus-eluting stent in coronary bifurcation lesions) study.
    Dubois C; Adriaenssens T; Ughi G; Wiyono S; Bennett J; Coosemans M; Ferdinande B; Sinnaeve P; D'hooge J; Desmet W
    Catheter Cardiovasc Interv; 2013 Feb; 81(3):E155-64. PubMed ID: 22745031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Valentines Trial: results of the first one week worldwide multicentre enrolment trial, evaluating the real world usage of the second generation DIOR paclitaxel drug-eluting balloon for in-stent restenosis treatment.
    Stella PR; Belkacemi A; Waksman R; Stahnke S; Torguson R; von Strandmann RP; Agostoni P; Sangiorgi G; Silber S;
    EuroIntervention; 2011 Oct; 7(6):705-10. PubMed ID: 21959672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DANUBIO - a new drug-eluting balloon for the treatment of side branches in bifurcation lesions: six-month angiographic follow-up results of the DEBSIDE trial.
    Berland J; Lefèvre T; Brenot P; Fajadet J; Motreff P; Guerin P; Dupouy P; Schandrin C;
    EuroIntervention; 2015 Dec; 11(8):868-76. PubMed ID: 26696455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial of a dedicated bifurcation stent versus provisional stenting in the treatment of coronary bifurcation lesions.
    Généreux P; Kumsars I; Lesiak M; Kini A; Fontos G; Slagboom T; Ungi I; Metzger DC; Wykrzykowska JJ; Stella PR; Bartorelli AL; Fearon WF; Lefèvre T; Feldman RL; LaSalle L; Francese DP; Onuma Y; Grundeken MJ; Garcia-Garcia HM; Laak LL; Cutlip DE; Kaplan AV; Serruys PW; Leon MB
    J Am Coll Cardiol; 2015 Feb; 65(6):533-43. PubMed ID: 25677311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial intravascular ultrasound analysis of complex bifurcation coronary lesions treated with the Tryton Bifurcation Stent in conjunction with an everolimus-eluting stent: IUVANT (Intravascular Ultrasound Evaluation of Tryton Stent) study.
    Bartorelli AL; Trabattoni D; Almonacid A; Fabbiocchi F; Montorsi P; Galli S; Grancini L; Ravagnani P; Mintz GS; Kaplan AV; Popma JJ; Maehara A
    Catheter Cardiovasc Interv; 2015 Mar; 85(4):544-53. PubMed ID: 25115944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term clinical and angiographic outcomes after implantation of sirolimus-eluting stents with a "modified mini-crush" technique in coronary bifurcation lesions.
    Yang HM; Tahk SJ; Woo SI; Lim HS; Choi BJ; Choi SY; Yoon MH; Park JS; Zheng M; Hwang GS; Kang SJ; Shin JH
    Catheter Cardiovasc Interv; 2009 Jul; 74(1):76-84. PubMed ID: 19360861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Segmental comparison between a dedicated bifurcation stent and balloon angioplasty using intravascular ultrasound and three-dimensional quantitative coronary angiography: A subgroup analysis of the Tryton IDE randomized trial.
    Grundeken MJ; Garcia-Garcia HM; Kumsars I; Lesiak M; Kayaert P; Dens J; Stella PR; de Winter RJ; Laak LL; Généreux P; Kaplan AV; Leon MB; Wykrzykowska JJ; Onuma Y; Serruys PW
    Catheter Cardiovasc Interv; 2017 Feb; 89(2):E53-E63. PubMed ID: 27083384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procedural and early clinical outcomes of patients with de novo coronary bifurcation lesions treated with the novel Nile PAX dedicated bifurcation polymer-free paclitaxel coated stents: results from the prospective, multicentre, non-randomised BIPAX clinical trial.
    Costa RA; Abizaid A; Abizaid AS; Garcia del Blanco B; Berland J; Petrov I; Brenot P; van Guens RJ; Royer T; Rubino P; Lesiak M; Fajadet J;
    EuroIntervention; 2012 Mar; 7(11):1301-9. PubMed ID: 22433193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Six-month clinical and angiographic results of the STENTYS® self-apposing stent in bifurcation lesions.
    Verheye S; Ramcharitar S; Grube E; Schofer JJ; Witzenbichler B; Kovac J; Hauptmann KE; Agostoni P; Wiemer M; Lefèvre T; Spaargaren R; Serruys PW; García-García HM; van Geuns RJ
    EuroIntervention; 2011 Sep; 7(5):580-7. PubMed ID: 21930462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results From the International Drug Coated Balloon Registry for the Treatment of Bifurcations. Can a Bifurcation Be Treated Without Stents?
    Bruch L; Zadura M; Waliszewski M; Platonic Z; Eränen J; Scheller B; Götting B; Herberger D; Palmieri C; Sinicròpi G; Motz W
    J Interv Cardiol; 2016 Aug; 29(4):348-56. PubMed ID: 27242273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Glider registry.
    Secco GG; Rittger H; Hoffmann S; Richardt G; Abdel-Wahab M; Reinecke H; Lotan C; Werner G; Sievert H; Foin N; Di Mario C
    Catheter Cardiovasc Interv; 2017 Jan; 89(1):E1-E6. PubMed ID: 23729282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of bifurcation lesions with a drug-eluting balloon: the PEPCAD V (Paclitaxel Eluting PTCA Balloon in Coronary Artery Disease) trial.
    Mathey DG; Wendig I; Boxberger M; Bonaventura K; Kleber FX
    EuroIntervention; 2011 May; 7 Suppl K():K61-5. PubMed ID: 22027730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.